Human Apolipoprotein A1/APOA1 enzyme-linked immunoassay kit

CAT: EH0319 Datasheet
Specification 96 Test
Sensitivity 91.61pg/ml (50 μl)
Standard Curve Range 468.75 ~30000 pg/ml
Standard Curve Gradient 7 Points
Number of Incubations 2
Detectable sample Liquid phase sample of soluble substances. For example: serum, plasma, cell culture supernatant, tissue grinding liquid, etc.
Sample Volume 50 μl
Type Fully Ready-to-Use
Operation Duration 120min
pg/ml O.D. Average Corrected
0.00 0.0091 0.0093 0.0092
468.75 0.0140 0.0140 0.0140 0.0048
937.50 0.0294 0.0286 0.0290 0.0198
1875.00 0.0781 0.0818 0.0800 0.0708
3750.00 0.2654 0.2686 0.2670 0.2578
7500.00 0.8807 0.8709 0.8758 0.8666
15000.00 2.1960 2.2280 2.2120 2.2028
30000.00 4.4280 4.2416 4.3348 4.3256

Precision

Intra-assay Precision Inter-assay Precision
Sample Number S1 S2 S3 S1 S2 S3
22 22 22 6 6 6
Average(pg/ml) 411.0 2699.3 8436.9 609.6 2786.8 8924.8
Standard Deviation 24.2 110.0 280.3 21.2 15.1 427.6
Coefficient of Variation(%) 5.9 4.1 3.3 3.5 0.5 4.8

Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty-two times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.

Spike Recovery

The spike recovery was evaluated by spiking 3 levels of human Apolipoprotein A1/APOA1 into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 93% to 120% with an overall mean recovery of 107%.

Sample Values

Sample Matrix Sample Evaluated Range (μg/ml) Detectable (%) Mean of Detectable (μg/ml)
Serum30683.85-2777.781001035.81

Serum/Plasma – Thirty samples from apparently healthy volunteers were evaluated for the presence of human Apolipoprotein A1/APOA1 in this assay. No medical histories were available for the donors. n.d. = non-detectable. Samples measured below the sensitivity are considered to be non-detectable.

Background: Apolipoprotein A1/APOA1

At least 9 distinct polymorphic forms of apolipoproteins are known. The apolipoproteins act as stabilizers of the intact lipoprotein particles. Quantitative measurements of HDL, LDL and VLDL particles in human serum are often used to estimate an individuals' relative risk of coronary heart disease. In addition, quantitative immunological measurements of certain apolipoproteins (especially A-1 and B) have been suggested to be more accurate estimators of coronary heart disease than measurements of lipoprotein particles (especially HDL and LDL). This apo-lipoprotein is derived from human plasma by density gradient ultracentrifugation and HPLC.

Under construction!

Under construction!

Under construction!

Contact Information
Related Products
相关途径
Guarantee